相关实验视频

Updated: Jul 5, 2025

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

质母细胞瘤及其治疗与广泛的加速大脑衰老有关

Anna P Ainslie^1,2,3, Myrthe Klaver^1,2,3, Daniëlle C Voshart^1,2

¹Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

|January 18, 2024

概括

质母细胞瘤 (GBM) 患者的大脑表现出加速衰老的线粒体功能障碍和炎症,即使在非瘤区域. 这些变化类似于阿尔茨海默病 (AD) 的衰老模式,这表明对脑瘤的副作用有新的治疗点.

科学领域:

神经科学是一个神经科学.
在瘤学瘤学.
衰老研究研究衰老研究

背景情况:

神经认知功能障碍显著影响原发性脑瘤患者的生活质量.
了解大脑对癌症和治疗的反应对于管理认知衰退至关重要.

研究的目的:

为了调查质母细胞瘤 (GBM) 患者在看起来正常的大脑组织中的分子和细胞变化.
为了将这些变化与未受影响的对照和阿尔茨海默病 (AD) 患者的变化进行比较.

主要方法:

死亡后脑样本的综合转录和组织分析.
对非瘤GBM组织,对照组织和AD患者组织的比较分析.
在蛋白质水平上验证发现.

主要成果:

看起来正常的GBM脑组织表现出加速衰老的特征:线粒体功能障碍,炎症和蛋白质稳定性放松调节.
这些衰老特征随着接近瘤而减少.
在GBM和AD患者之间观察到基因表达和生物衰老轨迹的显著重叠.
蛋白质水平验证证实GBM非瘤大脑区域增加了脂素,酸化和氧化DNA损伤.

结论:

GBM患者的大脑经历了加速衰老,具有类似AD的特征.
这些发现表明了管理GBM相关认知副作用的潜在治疗点.

关键词:

衰老的标志衰老的标志癌症治疗副作用癌症治疗副作用认知能力下降认知能力下降质母细胞瘤 (glioblastoma) 是一种神经退行症的神经退行症

更多相关视频

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...